China stents market is projected to register a substantial CAGR of 5.5% through 2025 attributing to increasing prevalence of cardiovascular disorders in the country. Reportedly, 2 out of 5 deaths in China are a result of cardiovascular disease. Moreover, increasing inclination of market players toward new product development will provide positive growth prospects for the industry in the near future.

The burgeoning number of peripheral and coronary artery surgical procedures across the world is a key factor expected to accelerate the stents market over the forecast period. In recent years, there has been a growing prevalence of cardiovascular diseases worldwide primarily due to the adoption of a sedentary and unhealthy lifestyle.

Get sample copy of this research report @

In terms of material bifurcation, Polymer stent segment is anticipated to register USD 3.0 billion by 2026 considering the massive usage of polyethylene, polyurethanes, polylactides and polyglycolides due to their biostable and biodegradable properties. In addition, various benefits associated with polymer stents such as high compatibility and minimum post-surgery complications, will complement the segment growth further.

In terms of product type, self-expandable stents segment is projected to register a valuation of USD 5.3 billion by 2026 on account of increasing product adoption owing to its ability to attain the required diameter after placement. Moreover, various benefits associated with self-expandable stents such as enhanced durability and excellent long-term patency rates is likely to impel the adoption of self-expandable stents further. Besides, these stents find important application for the treatment of patients suffering from femoropopliteal disease. For the records, the segment had accounted for a sizeable market share of 36.1% in 2019.

Based on end-use, hospital segment had recorded an appreciable valuation of around USD 8.3 billion in the past and is expected to observe a steady growth over the following years. This can be credited to increased patient inclination towards these healthcare settings due to the availability of technologically advanced equipment and improved facilities. Further, strict implementation of guidelines in hospital settings provide enhanced patient safety and ensures better surgical outcomes which will foster the segment growth significantly.

The company developed this product to address the risk of stent thrombosis related to delayed healing found with traditional drug-eluting stents. With the advent of such products with minimal re-obstruction rate, it comes as no surprise that the stents market will record lucrative growth over the forecast period. Notably, companies such as Meril Life Sciences, Elixir Medical Corporation, Biotronik, Biosensors International Group, Terumo, Boston Scientific, Medtronic, MicroPort Scientific Corporation, B. Braun Melsungen AG, and Abbott Laboratories are currently at the forefront of the stents market.

Request for a Customization of this research report @

Partial Chapter of the Table of Content

Chapter 6   Stents Market, By Type

6.1    Key segment trend

6.2    Self-expandable stents

6.2.1    Market size, by region, 2015 – 2026 (USD Million)

6.2.2    Market size, by region, 2015 – 2026 (Units)

6.3    Balloon-expandable stents

6.3.1    Market size, by region, 2015 – 2026 (USD Million)

6.3.2    Market size, by region, 2015 – 2026 (Units)

Chapter 7   Stents Market, By End-use

7.1    Key segment trend

7.2    Hospitals

7.2.1    Market size, by region, 2015 – 2026 (USD Million)

7.2.2    Market size, by region, 2015 – 2026 (Units)

7.3    Ambulatory surgical centers

7.3.1    Stents Market size, by region, 2015 – 2026 (USD Million)

7.3.2    Market size, by region, 2015 – 2026 (Units)

Charts & Figures

FIG. 1    Top-down approach

FIG. 2    Breakdown of primary participants

FIG. 3    Stents industry 3600 synopsis

FIG. 4    Industry segmentation

FIG. 5    Global stents market, 2015 - 2026 (USD Million)

FIG. 6    Growth potential analysis, by product

FIG. 7    Growth potential analysis, by material

FIG. 8    Growth potential analysis, by type

FIG. 9    Growth potential analysis, by end-use

FIG. 10 Global market share analysis, 2019

FIG. 11 Porter’s analysis

FIG. 12 Global company market share analysis, 2019

FIG. 13 Company matrix analysis, 2019

FIG. 14 PESTEL analysis

Browse complete Table of Contents (ToC) of this research report @